TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY

TherapeuticsMD (NASDAQ: TXMD) reported a Q4 loss of $(0.06) per share, a significant decline from earnings of $0.01 per share in the same quarter last year, marking a 700% decrease. However, the company achieved sales of $893,000, which represents a 33.88% increase compared to $667,000 in the previous year.